Western Oncolytics is developing a new generation of optimized, multi-mechanistic cancer immunotherapies. Our oncolytic viral immunotherapies are designed with proprietary, synergistic combinations of genetic modifications to be well-tolerated and to systemically find and destroy cancer cells while enhancing patients’ anti-tumor immune response. Western Oncolytics is committed to creating a best-in-class immuno-oncology platform to help patients across the globe beat cancer. Our unique approach to developing next-generation oncolytic viral immunotherapies stems from: A) using vaccinia virus as an ideal systemic delivery platform template B) enhancing the vaccinia backbone with a proprietary combination of genetic modifications and insertions to achieve optimal oncolytic potential, including systemic delivery and spread within the tumor. C) adding therapeutic transgenes for synergistic, multi-mechanistic immunotherapeutic effects.